510(k) Report

PMA · Approved

Recalled · Class I · 2026

MiniMed 670G System

P160017PMAApproved Sep 28, 2016104-day reviewClass IIIRecalls 14 (2 Class I)

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medtronic Minimed, Inc. · OZP Automated Insulin Dosing Device System, Single Hormonal Control

Approved on Sep 28, 2016 through premarket approval, which rests on the device’s own clinical evidence after a 104-day review. It has a Class I recall. It has been recalled 14 times, including 2 Class I recalls.

Decided
Sep 28, 2016
Review
104 days
Class
Class III
Product code
OZP
Recalls
14 (2 Class I)

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P160017 has 126 supplements since 2016: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

2016: 62017: 152018: 282019: 212020: 82021: 62022: 82023: 72024: 72025: 142026: 6
2016high 28 (2018) · low 6 (2016)2026
View FIG. 1 as a table
YearSupplements approved
20166
201715
201828
201921
20208
20216
20228
20237
20247
202514
20266
FIG. 1 — Supplements to P160017, 2016–2026Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (1 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jul 13, 2026Class IIZ-2981-2026Process designLoaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing hypoglycemia…
Feb 13, 2026Class IIZ-1742-2026Device DesignAll Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site…
Feb 13, 2026Class IIZ-1739-2026Device DesignAll Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site…
Jan 31, 2025Class IIZ-1261-2025Device DesignAll Medtronic MiniMed pumps (Paradigm series, Minimed 530G, 6XX series, and 7XX series) were found to have the potential for abnormal insulin delivery due to changes in air pressure, which can be found during airplane take-off or landing.…
Jan 31, 2025Class IIZ-1266-2025Device DesignAll Medtronic MiniMed pumps (Paradigm series, Minimed 530G, 6XX series, and 7XX series) were found to have the potential for abnormal insulin delivery due to changes in air pressure, which can be found during airplane take-off or landing.…
Jan 31, 2025Class IIZ-1265-2025Device DesignAll Medtronic MiniMed pumps (Paradigm series, Minimed 530G, 6XX series, and 7XX series) were found to have the potential for abnormal insulin delivery due to changes in air pressure, which can be found during airplane take-off or landing.…
Jul 31, 2024Class IZ-0003-2025Device DesignInsulin pumps that have been dropped, bumped, or experienced physical impact may have damage to internal electrical components, which may cause reduced pump battery life. Since the defect reduces the battery life overall, it shortens the…
Sep 20, 2022Class IIZ-0193-2023Component change controlMedtronic identified a cybersecurity vulnerability in the MiniMed 600 series Insulin Pump Systems associated with the communication protocol that could allow unauthorized access to the pump system. This unauthorized access could be used…
Jan 27, 2022Class IIZ-0855-2022Labeling designNew or replacement insulin pumps are not pre-programmed with basal rates or other verified settings (bolus wizard settings, sensor settings, etc.), which must be set up and saved on pumps prior to use. Patients who do not realize this…
Mar 15, 2021Class IIZ-1771-2021Software designDue to a software design issue, under certain conditions, a software fault is detected when a large bolus delivery at quick bolus speed completes. if the user is not aware of the amount of active insulin and delivers an additional bolus…
Apr 30, 2020Class IIZ-0516-2021Nonconforming Material/ComponentMissing solder battery connection, which could interrupt power of insulin pump.
Nov 21, 2019Class IZ-0956-2020Device DesignThere have been reported incidents of a loose reservoir that can no longer be locked into the pump. The reservoir can become loose due to a broken or missing retainer ring that prevents a proper lock. If the reservoir is not properly…
May 8, 2017Class IIZ-2605-2017Device DesignMedtronic MiniMed is recalling the MiniMed 600 series insulin pump because it may become temporarily stuck, and the keypad becomes unresponsive.
May 8, 2017Class IIZ-2604-2017Device DesignMedtronic MiniMed is recalling the MiniMed 600 series insulin pump because it may become temporarily stuck, and the keypad becomes unresponsive.

No ancestor or descendant has a Class I recall.

How does its category compare?

All OZP devices

OZP Automated Insulin Dosing Device System, Single Hormonal Control: FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.

FDA decisions per year · OZP

14in 2025

2016: 72017: 152018: 282019: 212020: 82021: 62022: 72023: 72024: 72025: 142026 (partial year): 6
2007high 28 (2018) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OZP

Too few OZP 510(k)s in any year since 2007 to give a median.

Recalls per year · OZP

1in 2024

2019: 3, 3 Class I2020: 12022: 22023: 12024: 1, 1 Class I2026 (partial year): 1
2007high 3 (2019) · low 0 (2007)2026

Class I (4 since 2007) Class II/III not classified

Adverse event reports per year · OZP

150,968in 2025

2015: 132016: 632017: 3,6062018: 30,8492019: 55,5072020: 74,0422021: 66,2212022: 154,9322023: 145,1982024: 129,5842025: 150,968
2007high 154,932 (2022) · low 0 (2007)2025

MAUDE reports naming product code OZP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—013
20167—063
201715—03,606
201828—030,849
201921—3 (3)55,507
20208—174,042
20216—066,221
20227—2154,932
20237—1145,198
20247—1 (1)129,584
202514—0150,968
20266—1—
Cite this page

510(k) Report. “P160017: MiniMed 670G System.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/P160017

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026